Insights

Stay abreast of key issues and critical thinking within the European rare disease community.

Medical affairs challenges for orphan drugs: the key to a winning KOL engagement strategy
How real-world evidence is changing Health Technology Assessment (HTA) submissions
Pharmacovigilance and regulatory affairs: an introduction to drug safety monitoring and the role of outsourcing
The pharmaceutical supply chain: a breakdown of the key components
Launching pharmaceuticals in Belgium, the Netherlands, and Luxembourg: opportunities and challenges
Improving health equity in Europe’s small countries: how can we remove the barriers to access?
Launching pharmaceuticals in the Nordics: opportunities and challenges
Navigating market access in Sweden
ESG in pharma: meeting requirements in the Nordic region
The power of joint procurement: analysing cross-border initiatives in Benelux and the Nordics

Press Room

Discover the latest corporate news from AMPS, along with press releases and company announcements.